Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma

被引：0

作者：

I Sekine

H Nokihara

A Horiike

N Yamamoto

H Kunitoh

Y Ohe

T Tamura

T Kodama

N Saijo

机构：

[1] National Cancer Center Hospital,Divisions of Internal Medicine and Thoracic Oncology

[2] Tsukiji 5-1-1,undefined

[3] Chuo-ku,undefined

来源：

British Journal of Cancer | 2004年 / 90卷

关键词：

squamous cell carcinoma; paclitaxel; nedaplatin; lung cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The recommended phase II dose of paclitaxel 180 mg m−2 given as a 3-h infusion followed by nedaplatin 100 mg m−2 in a 1-h infusion every 3–4 weeks was determined in 52 chemo-naive patients with unresectable squamous cell carcinoma (SCC), with a promising response rate for lung SCC of 55%.

引用

页码：1125 / 1128

页数：3

共 50 条

[41] PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Herchenhorn, Daniel
Dias, Fernando L.
Viegas, Celia M. P.
Federico, Miriam H.
Araujo, Carlos Manoel M.
Small, Isabelle
Bezerra, Marcos
Fontao, Karina
Knust, Renata E.
Ferreira, Carlos G.
Martins, Renato G.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 696 - 702
[42] Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302
Takashi Kasai
Kiyoshi Mori
Tomohide Sugiyama
Nobuyuki Koyama
Yoichi Nakamura
Fumiyoshi Ohyanagi
Hiroki Fukuda
Eishin Hoshi
Kunihiko Kobayashi
Mitsuo Nakayama
International Journal of Clinical Oncology, 2022, 27 : 1841 - 1848
[43] Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma
Adachi, S
Ogasawara, T
Wakimoto, E
Tsuji, Y
Takemura, T
Koyama, K
Takayasu, Y
Inoue, J
Nakao, N
CANCER, 2001, 91 (01) : 74 - 79
[44] A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma
Li, Yifan
Zeng, Jing
Huang, Manni
An, Jusheng
Bai, Ping
Wu, Lingying
Zhang, Rong
CANCER, 2017, 123 (03) : 420 - 425
[45] Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancer
Nagata, N
Kobayashi, M
Kojima, H
Kondo, K
Hirabayashi, N
Matsui, T
Kataoka, M
Takiyama, W
Miyashita, Y
Nakazato, H
Araki, A
Itoh, H
Nakao, A
Sakamoto, J
HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1905 - 1910
[46] Phase II Study of Concurrent Chemo Irradiation with Weekly Cisplatin and Paclitaxel in the Treatment of Locally Advanced Squamous Cell Carcinoma of Cervix
Varghese, S.
Ram, T.
Pavamani, S.
Thomas, E.
Jeyaseelan, V.
Viswanathan, P.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S398 - S398
[47] Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study
Stier, S
Koll, C
Neuhaus, T
Fronhoffs, S
Forkert, R
Tuohimaa, A
Vetter, H
Ko, Y
ANTI-CANCER DRUGS, 2005, 16 (10) : 1115 - 1121
[48] Phase I study of Paclitaxel, Cisplatin and 5-fluorouracil combination chemotherapy for unresectable/recurrent gastric cancer
Kato, J.
Nagahara, A.
Iijima, K.
Kodani, T.
Higashihara, Y.
Yoshimura, M.
Serizawa, N.
Osada, T.
Yoshizawa, T.
Otaka, M.
Watanabe, S.
ADVANCES IN MEDICAL SCIENCES, 2010, 55 (02): : 137 - 142
[49] Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus
Polee, MB
Tilanus, HW
Eskens, FALM
Hoekstra, R
Van der Burg, MEL
Siersema, PD
Stoter, G
Van der Gaast, A
ANNALS OF ONCOLOGY, 2003, 14 (08) : 1253 - 1257
[50] Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma
Tak Yun
Ji-Youn Han
Jin Soo Lee
Hyun Lee Choi
Hyae Young Kim
Byung-Ho Nam
Heung Tae Kim
BMC Cancer, 11

← 1 2 3 4 5 →